LecTec Corporation Launches First Patch Product for Kids
into the $2.4 Billion Cough/Cold Market: TheraPatch Vapor Cherry Patch for Kids

MINNETONKA, Minn. -- August 31, 1999 -- LecTec Corporation (Nasdaq National Market:LECT) today announced the launch of its new TheraPatch(R) Vapor Cherry patch "For Kids" product. TheraPatch Vapor Cherry Patch "For Kids" provides temporary relief of coughs due to colds, as well as minor sore throat and bronchial irritations caused by coughs due to colds.

TheraPatch Vapor Cherry Patch "For Kids" is the first children's vapor-action patch introduced to the growing $2.4 billion cough/cold market. TheraPatch Vapor Cherry Patch "For Kids" was invented as a convenient, non-messy alternative to those sticky vapor ointments that rub off on your child's pajamas or their bed sheets. The Company is presently shipping initial orders to national food, drug and mass retail chains.

LecTec continues to focus its over-the-counter patch product development in the areas of external analgesics, first aid, cough/cold relief and skin care. TheraPatch Vapor Cherry Patch "For Kids" is the seventh product in the TheraPatch product family introduced within the past twelve months. Launched into national retail chains in late September 1998, the TheraPatch family of products include: TheraPatch Cool and TheraPatch Warm which provide temporary relief from minor aches and pains; TheraPatch Anti-Itch "For Kids" and TheraPatch Anti-Itch "Outdoors" which provide temporary relief from the itching and pain associated with insect bites, minor skin irritations, and rashes due to poison ivy/oak/sumac; and TheraPatch Vapor Chest, TheraPatch Vapor Nose & Chin and now TheraPatch Vapor Cherry Patch "For Kids," which provide temporary relief from coughs due to colds.

A pipeline of innovative, new products, patented patch technology, and the company's ability to be fast and flexible are the Company's stated competitive advantages.

LecTec is a health care and consumer products company that develops, manufactures and markets products based on its advanced skin interface technologies. Primary products include over-the-counter patch products, diagnostic electrodes and conductive hydrogels for electrocardiography and related applications, and a full line of medical tapes.

This press release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the company and its management. These forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that may cause the Company's actual results to differ materially from the results discussed in these statements. Factors that might cause such differences include, but are not limited to, buying patterns of major customers, market acceptance of LecTec's products, competitive products, availability of capital to finance growth, regulatory risks and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Contact: LecTec Corp., Minnetonka Rodney A. Young, CEO or 
Timothy R. J. Quinn, General Manager Consumer Products Division (612) 933-2291